Nectar Lifesciences Limited (NSE:NECLIFE)
India · Delayed Price · Currency is INR 14.62
+0.08 (0.55%)
At close: Jan 23, 2026
Nectar Lifesciences Market Cap
Nectar Lifesciences has a market cap or net worth of 2.84 billion as of January 23, 2026. Its market cap has decreased by -67.85% in one year.
Market Cap
2.84B
Enterprise Value
7.36B
Revenue
16.70B
Ranking
n/a
PE Ratio
n/a
Stock Price
14.62
Market Cap Chart
Since July 18, 2005, Nectar Lifesciences's market cap has decreased from 2.87B to 2.84B, a decrease of -0.88%. That is a compound annual growth rate of -0.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 2.84B | -34.75% |
| Dec 31, 2025 | 4.35B | -50.21% |
| Dec 31, 2024 | 8.74B | 21.24% |
| Dec 29, 2023 | 7.21B | 30.96% |
| Dec 30, 2022 | 5.51B | -8.40% |
| Dec 31, 2021 | 6.01B | 12.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beta Drugs | 15.07B |
| Jagsonpal Pharmaceuticals | 11.00B |
| Sakar Healthcare | 9.36B |
| Sigachi Industries | 9.06B |
| Ind-Swift Laboratories | 8.67B |
| Valiant Laboratories | 3.13B |
| Bafna Pharmaceuticals | 2.65B |
| Brooks Laboratories | 1.92B |